Literature DB >> 4810107

Letter: Anhydrous theophylline equivalence of commercial theophylline formulations.

E F Ellis, E D Eddy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4810107     DOI： 10.1016/0091-6749(74)90073-6

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  4 in total

1.  Rational use of oral theophylline in the treatment of chronic asthma.

Authors:  M L Franz; S P Galant
Journal:  West J Med       Date:  1975-06

Review 2.  Clinical pharmacokinetics of theophylline.

Authors:  R I Ogilvie
Journal:  Clin Pharmacokinet       Date:  1978 Jul-Aug       Impact factor: 6.447

Review 3.  Clinical relevance of pharmacokinetics.

Authors:  G Tognoni; C Bellantuono; M Bonati; M D'Incalci; M Gerna; R Latini; M Mandelli; M G Porro; E Riva
Journal:  Clin Pharmacokinet       Date:  1980 Mar-Apr       Impact factor: 6.447

Review 4.  Therapeutic monitoring of theophylline. Rationale and current status.

Authors:  C W Bierman; P V Williams
Journal:  Clin Pharmacokinet       Date:  1989-12       Impact factor: 6.447
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.